SLC16A2 Gene

HGNC Family Solute carriers (SLC)
Name solute carrier family 16, member 2 (thyroid hormone transporter)
Description This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC16A2, which encodes monocarboxylate transporter 8 (MCT8), is a highly specific, energy‐independent transmembrane protein that mediates the cellular uptake and efflux of iodothyronines—especially triiodothyronine (T3)—thereby regulating thyroid hormone (TH) bioavailability at the cellular level. Its discovery, through analyses of gene deletions and missense mutations associated with severe psychomotor retardation and abnormal TH serum profiles, established MCT8 as the principal TH transporter whose function is critical for proper neuronal signaling and development."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nExpression studies show that MCT8 is predominantly localized in neurons and is also found in other critical regions such as the blood–brain barrier, choroid plexus, and even oligodendrocytes. During brain development, MCT8 expression in these cell populations ensures efficient T3 delivery to key target cells, and its distribution in the cerebral microvasculature and in placental tissues supports its role in regulating both central and peripheral TH supply."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMutations in SLC16A2 are causative for disorders such as Allan–Herndon–Dudley syndrome, which is characterized by severe intellectual and motor impairments alongside atypical thyroid hormone profiles (with elevated free T3 and low or normal thyroxine and rT3 levels). Functional investigations in patient-derived cells and animal models have demonstrated that loss-of-function mutations impede T3 uptake into neurons, thereby disrupting intracellular T3 metabolism and signaling—a defect that underlies the profound neurodevelopmental deficits observed in these patients."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDetailed molecular and structural analyses have provided additional insights into MCT8 function. Investigations indicate that MCT8 may operate as a monomer or homodimer and that specific amino acid residues—such as His192, which is sensitive to chemical modification—are critical for substrate recognition and transport activity. Moreover, a comparative evaluation with closely related transporters (for example, MCT10) underscores the unique specificity of MCT8 for iodothyronines, and studies in different cell types have revealed that subcellular trafficking and membrane localization of MCT8 can vary, potentially contributing to tissue‐specific differences in TH signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its central role in brain development, MCT8 is expressed in extraneural tissues such as the placenta, where its regulated expression is thought to modulate transplacental TH passage and ensure proper fetal growth—a process that may be altered in conditions like intrauterine growth restriction. Emerging evidence from studies on various physiological and pathophysiological models further highlights the broad significance of MCT8 in regulating TH homeostasis across tissues, with implications extending even to contexts such as cancer cell metabolism."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, the body of research on SLC16A2/MCT8 underscores its essential function as the gatekeeper for thyroid hormone entry into cells—a role that is indispensable for the maintenance of TH‐dependent gene regulation and neurodevelopment. Disruptions in MCT8 function, whether due to point mutations affecting transporter kinetics or perturbations in its cellular localization, lead to profound clinical syndromes characterized by neurocognitive deficits and altered peripheral TH metabolism.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Edith C H Friesema, Annette Grueters, Heike Biebermann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(04)17226-7"}], "href": "https://doi.org/10.1016/S0140-6736(04"}, {"type": "t", "text": "17226-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15488219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15488219"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Charles E Schwartz, Melanie M May, Nancy J Carpenter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/431313"}], "href": "https://doi.org/10.1086/431313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15889350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15889350"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lori M Roberts, Kathleen Woodford, Mei Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2008-0378"}], "href": "https://doi.org/10.1210/en.2008-0378"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18687783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18687783"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Edith C H Friesema, Jurgen Jansen, Jan-Willem Jachtenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0112"}], "href": "https://doi.org/10.1210/me.2007-0112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18337592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18337592"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Heike Heuer, Michael K Maier, Sandra Iden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2004-1179"}], "href": "https://doi.org/10.1210/en.2004-1179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15661862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15661862"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Edith C H Friesema, George G J M Kuiper, Jurgen Jansen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2005-0256"}], "href": "https://doi.org/10.1210/me.2005-0256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16887882"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16887882"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Eva K Wirth, Stephan Roth, Cristiane Blechschmidt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.6055-08.2009"}], "href": "https://doi.org/10.1523/JNEUROSCI.6055-08.2009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19641107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19641107"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daniela López-Espíndola, Carmen Morales-Bastos, Carmen Grijota-Martínez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2014-2162"}], "href": "https://doi.org/10.1210/jc.2014-2162"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25222753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25222753"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Anita Kinne, Gunnar Kleinau, Carolin S Hoefig, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.129577"}], "href": "https://doi.org/10.1074/jbc.M110.129577"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20628049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20628049"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "L S Loubière, E Vasilopoulou, J N Bulmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2010.01.013"}], "href": "https://doi.org/10.1016/j.placenta.2010.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20167367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20167367"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jurgen Jansen, Edith C H Friesema, Monique H A Kester, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2007-1475"}], "href": "https://doi.org/10.1210/en.2007-1475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18187543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18187543"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Edith C H Friesema, Jurgen Jansen, Heike Heuer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Clin Pract Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncpendmet0262"}], "href": "https://doi.org/10.1038/ncpendmet0262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16957765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16957765"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Knut Brockmann, Alexandra M Dumitrescu, Thomas T Best, et al. "}, {"type": "b", "children": [{"type": "t", "text": "X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00415-005-0713-3"}], "href": "https://doi.org/10.1007/s00415-005-0713-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15834651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15834651"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jurgen Jansen, Edith C H Friesema, Monique H A Kester, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2006-2570"}], "href": "https://doi.org/10.1210/jc.2006-2570"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17356046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17356046"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "W Edward Visser, Jurgen Jansen, Edith C H Friesema, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.20808"}], "href": "https://doi.org/10.1002/humu.20808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18636565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18636565"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "W Edward Visser, Paul Vrijmoeth, Frank E Visser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cen.12023"}], "href": "https://doi.org/10.1111/cen.12023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22924588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22924588"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Anita Kinne, Stephan Roth, Heike Biebermann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/JME-09-0043"}], "href": "https://doi.org/10.1677/JME-09-0043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19648159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19648159"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Catherine Vaurs-Barrière, Marlène Deville, Catherine Sarret, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.21579"}], "href": "https://doi.org/10.1002/ana.21579"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19194886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19194886"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Loredana Boccone, Valentina Dessì, Antonella Meloni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejmg.2013.02.001"}], "href": "https://doi.org/10.1016/j.ejmg.2013.02.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23419639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23419639"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Alies A van Mullem, Anja L M van Gucht, W Edward Visser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of thyroid hormone transporters MCT8 and MCT10 on nuclear activity of T3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2016.07.037"}], "href": "https://doi.org/10.1016/j.mce.2016.07.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27492966"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27492966"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "S R James, J A Franklyn, B J Reaves, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Monocarboxylate transporter 8 in neuronal cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2008-1031"}], "href": "https://doi.org/10.1210/en.2008-1031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19022891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19022891"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ferdy S van Geest, Nilhan Gunhanlar, Stefan Groeneweg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Endocrinol (Lausanne) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fendo.2021.723750"}], "href": "https://doi.org/10.3389/fendo.2021.723750"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34539576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34539576"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ahmet Anık, Simone Kersseboom, Korcan Demir, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Res Paediatr (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000365191"}], "href": "https://doi.org/10.1159/000365191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25247785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25247785"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "W Edward Visser, Nancy J Philp, Thamar B van Dijk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for a homodimeric structure of human monocarboxylate transporter 8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2009-0699"}], "href": "https://doi.org/10.1210/en.2009-0699"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19797118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19797118"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Stefan Groeneweg, Elaine C Lima de Souza, W Edward Visser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Importance of His192 in the human thyroid hormone transporter MCT8 for substrate recognition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2012-2225"}], "href": "https://doi.org/10.1210/en.2012-2225"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23610131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23610131"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Christine M Armour, Simone Kersseboom, Grace Yoon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0139343"}], "href": "https://doi.org/10.1371/journal.pone.0139343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26426690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26426690"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ganaelle Remerand, Odile Boespflug-Tanguy, Davide Tonduti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Med Child Neurol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/dmcn.14332"}], "href": "https://doi.org/10.1111/dmcn.14332"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31410843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31410843"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jae Young Lee, Min Joung Kim, Devy Deliyanti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2017.10.016"}], "href": "https://doi.org/10.1016/j.ebiom.2017.10.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29111262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29111262"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "W Edward Visser, Sigrid M A Swagemakers, Zeliha Ozgur, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional profiling of fibroblasts from patients with mutations in MCT8 and comparative analysis with the human brain transcriptome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddq337"}], "href": "https://doi.org/10.1093/hmg/ddq337"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20705735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20705735"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Greet L Roef, Ernst R Rietzschel, Tim De Meyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2013.08.017"}], "href": "https://doi.org/10.1016/j.cca.2013.08.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23978482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23978482"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "E Vasilopoulou, L S Loubière, A Martín-Santos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2010-0354"}], "href": "https://doi.org/10.1210/jc.2010-0354"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20660035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20660035"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Ehsan Sohrabi, Masoumeh Moslemi, Ehsan Rezaie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Genomics (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13258-021-01116-w"}], "href": "https://doi.org/10.1007/s13258-021-01116-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34097251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34097251"}]}]}]}
Synonyms MRX22, MCT 8, XPCT, MCT 7, AHDS, DXS128E, DXS128, MCT8, MCT7
Proteins MOT8_HUMAN
NCBI Gene ID 6567
API
Download Associations
Predicted Functions View SLC16A2's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC16A2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC16A2's ARCHS4 Predicted Functions.

Functional Associations

SLC16A2 has 6,540 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 119 datasets.

Click the + buttons to view associations for SLC16A2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC16A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC16A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC16A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC16A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC16A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC16A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SLC16A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC16A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC16A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with SLC16A2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC16A2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC16A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC16A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC16A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with SLC16A2 gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with SLC16A2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC16A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC16A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC16A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing SLC16A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing SLC16A2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC16A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC16A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC16A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC16A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC16A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC16A2 gene/protein from the curated CTD Gene-Disease Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SLC16A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving SLC16A2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SLC16A2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC16A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC16A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC16A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC16A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SLC16A2 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC16A2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC16A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC16A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC16A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SLC16A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC16A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC16A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC16A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC16A2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC16A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving SLC16A2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC16A2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC16A2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC16A2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC16A2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC16A2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC16A2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC16A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC16A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWASdb SNP-Disease Associations diseases associated with SLC16A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SLC16A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC16A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC16A2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SLC16A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC16A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC16A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with SLC16A2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC16A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC16A2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SLC16A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SLC16A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC16A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways 2026 pathways involving SLC16A2 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC16A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC16A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC16A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC16A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC16A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SLC16A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC16A2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC16A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SLC16A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC16A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC16A2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for SLC16A2 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC16A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SLC16A2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
OMIM Gene-Disease Associations phenotypes associated with SLC16A2 gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC16A2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC16A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC16A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC16A2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC16A2 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving SLC16A2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC16A2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC16A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC16A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC16A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC16A2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC16A2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with SLC16A2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of SLC16A2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of SLC16A2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SLC16A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SLC16A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC16A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC16A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC16A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC16A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC16A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC16A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving SLC16A2 protein from the WikiPathways Pathways 2024 dataset.